| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.497 | - | - | - | 23.183 | 22.020 | 28.152 | 39.568 | 42.755 | - |
| Total Income - EUR | 8.497 | - | - | - | 23.183 | 22.020 | 28.152 | 39.568 | 42.755 | - |
| Total Expenses - EUR | 4.226 | - | - | - | 14.753 | 13.337 | 20.399 | 12.047 | 33.923 | - |
| Gross Profit/Loss - EUR | 4.271 | - | - | - | 8.431 | 8.683 | 7.753 | 27.521 | 8.832 | - |
| Net Profit/Loss - EUR | 4.016 | - | - | - | 8.199 | 8.463 | 7.477 | 27.145 | 8.426 | - |
| Employees | 1 | - | - | - | 1 | 1 | 1 | 1 | 1 | - |
Check the financial reports for the company - Oftacare Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | - | - | - | 1.311 | 1.096 | 11.574 | 8.077 | 4.532 | - |
| Current Assets | 7.208 | - | - | - | 30.197 | 38.503 | 47.668 | 73.554 | 81.072 | - |
| Inventories | 0 | - | - | - | 0 | 0 | 0 | 497 | 495 | - |
| Receivables | 0 | - | - | - | 10.884 | 12.429 | 13.598 | 13.802 | 13.761 | - |
| Cash | 7.208 | - | - | - | 19.314 | 26.074 | 34.070 | 59.254 | 66.816 | - |
| Shareholders Funds | 6.947 | - | - | - | 30.313 | 38.202 | 45.269 | 72.555 | 80.761 | - |
| Social Capital | 45 | - | - | - | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 261 | - | - | - | 1.449 | 1.645 | 14.215 | 9.319 | 5.086 | - |
| Income in Advance | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oftacare Srl